EVC2 antibody (AA 1246-1308)
Quick Overview for EVC2 antibody (AA 1246-1308) (ABIN1833375)
Target
See all EVC2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1246-1308
-
Specificity
- Human EVC2
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide corresponding to a region within amino acids 1246 and 1308 of EVC2 (SwissProt Q86UK5).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: ICC (1:100 - 1:1000), WB (1:500 - 1:3000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.0, 10 % glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Keep as concentrated solution. Avoid multiple freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- EVC2 (Ellis Van Creveld Syndrome 2 (EVC2))
-
Alternative Name
- EVC2
-
Background
-
Name/Gene ID: EVC2
Synonyms: EVC2, Ellis van Creveld syndrome 2, LBN, Limbin -
Gene ID
- 132884
-
UniProt
- Q86UK5
-
Pathways
- Hedgehog Signaling
Target
-